EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 62007TB0169
Case T-169/07: Order of the Court of First Instance of 2 December 2008 — Longevity Health Products v OHIM — Hennig Arzneimittel (Cellutrim) (Community trade mark — Invalidity proceedings — Community word mark Cellutrim — Earlier national word mark Cellidrin — Likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 40/94 — Action in part manifestly inadmissible and in part manifestly lacking any foundation in law)
Case T-169/07: Order of the Court of First Instance of 2 December 2008 — Longevity Health Products v OHIM — Hennig Arzneimittel (Cellutrim) (Community trade mark — Invalidity proceedings — Community word mark Cellutrim — Earlier national word mark Cellidrin — Likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 40/94 — Action in part manifestly inadmissible and in part manifestly lacking any foundation in law)
Case T-169/07: Order of the Court of First Instance of 2 December 2008 — Longevity Health Products v OHIM — Hennig Arzneimittel (Cellutrim) (Community trade mark — Invalidity proceedings — Community word mark Cellutrim — Earlier national word mark Cellidrin — Likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 40/94 — Action in part manifestly inadmissible and in part manifestly lacking any foundation in law)
SL C 44, 21.2.2009, p. 46–47
(BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
- Date of document:
- 02/12/2008
- Date lodged:
- 16/05/2007
- Author:
- Sud prvog stupnja
- Form:
- Pravosudna informacija
- Authentic language:
- njemački
- Link
- Select all documents mentioning this document
- Instruments cited in case law:
- Link
|
21.2.2009 |
EN |
Official Journal of the European Union |
C 44/46 |
Order of the Court of First Instance of 2 December 2008 — Longevity Health Products v OHIM — Hennig Arzneimittel (Cellutrim)
(Case T-169/07) (1)
(Community trade mark - Invalidity proceedings - Community word mark Cellutrim - Earlier national word mark Cellidrin - Likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 40/94 - Action in part manifestly inadmissible and in part manifestly lacking any foundation in law)
(2009/C 44/81)
Language of the case: German
Parties
Applicant: Longevity Health Products, Inc. (Nassau, Bahamas) (represented by: J. Korab, lawyer)
Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: G. Schneider, acting as Agent)
Other party to the proceedings before the Board of Appeal of OHIM intervening before the Court of First Instance: Hennig Arzneimittel GmbH & Co. KG (Flörsheim, Germany) (represented by: S. Ziegler, C. Kleiner and F. Dehn, lawyers)
Re:
Action brought against the decision of the First Board of Appeal of OHIM of 7 March 2007 (Case R 1123/2006-1) concerning invalidity proceedings between, initially, Celltech Pharma GmbH & Co. KG and, subsequently, Hennig Arzneimittel GmbH & Co. KG and Longevity Health Products, Inc.
Operative part of the order
|
1. |
The action is dismissed. |
|
2. |
Longevity Health Products, Inc. is ordered to pay the costs. |
